{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:08:26Z","timestamp":1785150506854,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["K12AR084231"],"award-info":[{"award-number":["K12AR084231"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1245\/s10434-024-16805-5","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T22:20:46Z","timestamp":1736029246000},"page":"2510-2525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review"],"prefix":"10.1245","volume":"32","author":[{"given":"Koumani W.","family":"Ntowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria N.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett T.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-0558","authenticated-orcid":false,"given":"Jennifer K.","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"issue":"6","key":"16805_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3322\/caac.21754","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524\u201341. https:\/\/doi.org\/10.3322\/caac.21754.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"16805_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21440","volume":"68","author":"F Islami","year":"2018","unstructured":"Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31\u201354. https:\/\/doi.org\/10.3322\/caac.21440.","journal-title":"CA Cancer J Clin."},{"issue":"6","key":"16805_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/jco.18.01631","volume":"37","author":"PD Beitsch","year":"2019","unstructured":"Beitsch PD, Whitworth PW, Hughes K, et al. Underdiagnosis of hereditary breast cancer: Are genetic testing guidelines a tool or an obstacle? J Clin Oncol. 2019;37(6):453\u201360. https:\/\/doi.org\/10.1200\/jco.18.01631.","journal-title":"J Clin Oncol."},{"issue":"8","key":"16805_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5694\/mja2.51906","volume":"218","author":"DL De Silva","year":"2023","unstructured":"De Silva DL, Stafford L, Skandarajah AR, et al. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care. Med J Aust. 2023;218(8):368\u201373. https:\/\/doi.org\/10.5694\/mja2.51906.","journal-title":"Med J Aust."},{"issue":"1","key":"16805_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1245\/s10434-023-14394-3","volume":"31","author":"C Shelton","year":"2024","unstructured":"Shelton C, Ruiz A, Shelton L, et al. Universal germline-genetic testing for breast cancer: implementation in a rural practice and impact on shared decision-making. Ann Surg Oncol. 2024;31(1):325\u201334. https:\/\/doi.org\/10.1245\/s10434-023-14394-3.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"16805_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jso.27630","volume":"130","author":"KW Ntowe","year":"2024","unstructured":"Ntowe KW, Lee MS, Plichta JK. Clinical genetics in breast cancer. J Surg Oncol. 2024;130(1):16\u201322. https:\/\/doi.org\/10.1002\/jso.27630.","journal-title":"J Surg Oncol."},{"issue":"23","key":"16805_CR7","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402\u201316. https:\/\/doi.org\/10.1001\/jama.2017.7112.","journal-title":"JAMA."},{"issue":"2","key":"16805_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-017-4247-z","volume":"164","author":"JA Cintolo-Gonzalez","year":"2017","unstructured":"Cintolo-Gonzalez JA, Braun D, Blackford AL, et al. Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. Breast Cancer Res Treat. 2017;164(2):263\u201384. https:\/\/doi.org\/10.1007\/s10549-017-4247-z.","journal-title":"Breast Cancer Res Treat."},{"key":"16805_CR9","unstructured":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic (version 2.2024). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf"},{"issue":"4","key":"16805_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","volume":"212","author":"KK Ludwig","year":"2016","unstructured":"Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg. 2016;212(4):660\u20139. https:\/\/doi.org\/10.1016\/j.amjsurg.2016.06.010.","journal-title":"Am J Surg."},{"issue":"6","key":"16805_CR11","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1245\/s10434-022-13006-w","volume":"30","author":"AJ Webster","year":"2023","unstructured":"Webster AJ, Shanno JN, Santa Cruz HS, et al. Oncologic safety of nipple-sparing mastectomy for breast cancer in BRCA gene mutation carriers: outcomes at 70 months median follow-up. Ann Surg Oncol. 2023;30(6):3215\u201322. https:\/\/doi.org\/10.1245\/s10434-022-13006-w.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"16805_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00266-021-02506-x","volume":"46","author":"K Stanek","year":"2022","unstructured":"Stanek K, Zimovjanova M, Suk P, et al. Bilateral prophylactic nipple-sparing mastectomy: analysis of the risk-reducing effect in BRCA1\/2 mutation carriers. Aesthetic Plast Surg. 2022;46(2):706\u201311. https:\/\/doi.org\/10.1007\/s00266-021-02506-x.","journal-title":"Aesthetic Plast Surg."},{"issue":"10","key":"16805_CR13","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1245\/s10434-021-10445-9","volume":"28","author":"M Garstka","year":"2021","unstructured":"Garstka M, Henriquez A, Kelly BN, et al. How protective are nipple-sparing prophylactic mastectomies in BRCA1 and BRCA2 mutation carriers? Ann Surg Oncol. 2021;28(10):5657\u201362. https:\/\/doi.org\/10.1245\/s10434-021-10445-9.","journal-title":"Ann Surg Oncol."},{"key":"16805_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.amjsurg.2023.10.011","volume":"227","author":"SM Record","year":"2024","unstructured":"Record SM, Thomas SM, Ntowe K, et al. BRCA1\/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits. Am J Surg. 2024;227:146\u201352. https:\/\/doi.org\/10.1016\/j.amjsurg.2023.10.011.","journal-title":"Am J Surg."},{"key":"16805_CR15","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15793-w","author":"KW Ntowe","year":"2024","unstructured":"Ntowe KW, Thomas SM, Dalton JC, et al. Demographics and clinical decision making in patients with germline moderate penetrance non-brca mutations in breast cancer related genes. Ann Surg Oncol. 2024. https:\/\/doi.org\/10.1245\/s10434-024-15793-w.","journal-title":"Ann Surg Oncol."},{"issue":"24","key":"16805_CR16","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1200\/JCO.2007.13.9568","volume":"26","author":"Y Brandberg","year":"2008","unstructured":"Brandberg Y, Sandelin K, Erikson S, et al. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol. 2008;26(24):3943\u20139. https:\/\/doi.org\/10.1200\/JCO.2007.13.9568.","journal-title":"J Clin Oncol."},{"issue":"11","key":"16805_CR17","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1245\/s10434-011-1917-7","volume":"18","author":"MH Frost","year":"2011","unstructured":"Frost MH, Hoskin TL, Hartmann LC, Degnim AC, Johnson JL, Boughey JC. Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits. Ann Surg Oncol. 2011;18(11):3110\u20136. https:\/\/doi.org\/10.1245\/s10434-011-1917-7.","journal-title":"Ann Surg Oncol."},{"key":"16805_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01671-z","author":"R Sarkis-Onofre","year":"2021","unstructured":"Sarkis-Onofre R, Catal\u00e1-L\u00f3pez F, Aromataris E, Lockwood C. How to properly use the PRISMA statement. Syst Rev. 2021. https:\/\/doi.org\/10.1186\/s13643-021-01671-z.","journal-title":"Syst Rev."},{"key":"16805_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ."},{"issue":"9","key":"16805_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712\u20136. https:\/\/doi.org\/10.1046\/j.1445-2197.2003.02748.x.","journal-title":"ANZ J Surg."},{"issue":"1","key":"16805_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejso.2011.10.010","volume":"38","author":"Y Brandberg","year":"2012","unstructured":"Brandberg Y, Arver B, Johansson H, Wickman M, Sandelin K, Liljegren A. Less correspondence between expectations before and cosmetic results after risk-reducing mastectomy in women who are mutation carriers: a prospective study. Eur J Surg Oncol. 2012;38(1):38\u201343. https:\/\/doi.org\/10.1016\/j.ejso.2011.10.010.","journal-title":"Eur J Surg Oncol."},{"key":"16805_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.breast.2018.02.001","volume":"39","author":"D Casella","year":"2018","unstructured":"Casella D, Di Taranto G, Marcasciano M, et al. Nipple-sparing bilateral prophylactic mastectomy and immediate reconstruction with TiLoop\u00ae Bra mesh in BRCA1\/2 mutation carriers: a prospective study of long-term and patient reported outcomes using the BREAST-Q. The Breast. 2018;39:8\u201313. https:\/\/doi.org\/10.1016\/j.breast.2018.02.001.","journal-title":"The Breast."},{"issue":"1","key":"16805_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/13548500310001637760","volume":"9","author":"CME Contant","year":"2004","unstructured":"Contant CME, van Wersch AME, Menke-Pluymers MBE, et al. Satisfaction and prosthesis related complaints in women with immediate breast reconstruction following prophylactic and oncological mastectomy. Psychol Health Medi. 2004;9(1):71\u201384. https:\/\/doi.org\/10.1080\/13548500310001637760.","journal-title":"Psychol Health Medi"},{"issue":"3","key":"16805_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10689-012-9588-5","volume":"12","author":"JP Gopie","year":"2013","unstructured":"Gopie JP, Mureau MAM, Seynaeve C, et al. Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Fam Cancer. 2013;12(3):479\u201387. https:\/\/doi.org\/10.1007\/s10689-012-9588-5.","journal-title":"Fam Cancer."},{"issue":"5","key":"16805_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1159\/000505449","volume":"15","author":"R Klapdor","year":"2020","unstructured":"Klapdor R, Wei\u00df C, Kuehnle E, et al. Quality of life after bilateral and contralateral prophylactic mastectomy with implant reconstruction. Breast Care. 2020;15(5):519\u201326. https:\/\/doi.org\/10.1159\/000505449.","journal-title":"Breast Care."},{"issue":"2","key":"16805_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1023\/A:1015269620265","volume":"73","author":"LN Lodder","year":"2002","unstructured":"Lodder LN, Frets PG, Trijsburg RW, et al. One-year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat. 2002;73(2):97\u2013112. https:\/\/doi.org\/10.1023\/A:1015269620265.","journal-title":"Breast Cancer Res Treat."},{"issue":"7","key":"16805_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1055\/s-0037-1602785","volume":"33","author":"MA Manahan","year":"2017","unstructured":"Manahan MA, Baltodano PA, Reinhardt ME, et al. Psychosocial and aesthetic advantages of reconstruction after prophylactic mastectomy: a quality of life and aesthetic analysis. J Reconstr Microsurg. 2017;33(7):483\u201392. https:\/\/doi.org\/10.1055\/s-0037-1602785.","journal-title":"J Reconstr Microsurg."},{"issue":"10","key":"16805_CR28","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.21037\/gs-21-339","volume":"10","author":"M Maruccia","year":"2021","unstructured":"Maruccia M, Elia R, Tedeschi P, et al. Prepectoral breast reconstruction: an ideal approach to bilateral risk-reducing mastectomy. Gland Surg. 2021;10(10):2997\u20133006. https:\/\/doi.org\/10.21037\/gs-21-339.","journal-title":"Gland Surg."},{"issue":"9","key":"16805_CR29","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1245\/s10434-017-5915-2","volume":"24","author":"CM McCarthy","year":"2017","unstructured":"McCarthy CM, Hamill JB, Kim HM, et al. Impact of bilateral prophylactic mastectomy and immediate reconstruction on health-related quality of life in women at high risk for breast carcinoma: results of the mastectomy reconstruction outcomes consortium study. Ann Surg Oncol. 2017;24(9):2502\u20138. https:\/\/doi.org\/10.1245\/s10434-017-5915-2.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"16805_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00266-012-0044-6","volume":"37","author":"I Sahin","year":"2013","unstructured":"Sahin I, Isik S, Alhan D, Y\u0131ld\u0131z R, Aykan A, Ozturk E. One-staged silicone implant breast reconstruction following bilateral nipple-sparing prophylactic mastectomy in patients at high-risk for breast cancer. Aesthet Plast Surg. 2013;37(2):303\u201311. https:\/\/doi.org\/10.1007\/s00266-012-0044-6.","journal-title":"Aesthet Plast Surg."},{"issue":"4","key":"16805_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1006\/pmed.1995.1066","volume":"24","author":"ME Stefanek","year":"1995","unstructured":"Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F. Predictors of and satisfaction with bilateral prophylactic mastectomy. Prevent Med. 1995;24(4):412\u20139. https:\/\/doi.org\/10.1006\/pmed.1995.1066.","journal-title":"Prevent Med."},{"issue":"2","key":"16805_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/archdischild-2014-306953","volume":"101","author":"E de Vos-Kerkhof","year":"2016","unstructured":"de Vos-Kerkhof E, Geurts DH, Wiggers M, Moll HA, Oostenbrink R. Tools for \u2018safety netting\u2019 in common paediatric illnesses: a systematic review in emergency care. Arch Dis Child. 2016;101(2):131\u20139. https:\/\/doi.org\/10.1136\/archdischild-2014-306953.","journal-title":"Arch Dis Child."},{"key":"16805_CR33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.amjsurg.2023.10.011","volume":"227","author":"SM Record","year":"2024","unstructured":"Record SM, Thomas SM, Ntowe K, Chiba A, Plichta JK. BRCA1\/2 mutation carriers & risk reducing mastectomy: who undergoes surgery and potential benefits. Am J Surg. 2024;227:146\u201352. https:\/\/doi.org\/10.1016\/j.amjsurg.2023.10.011.","journal-title":"Am J Surg."},{"issue":"1","key":"16805_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10549-018-5057-7","volume":"174","author":"DA Henry","year":"2019","unstructured":"Henry DA, Lee MC, Almanza D, et al. Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited cancer registry (ICARE). Breast Cancer Res Treat. 2019;174(1):39\u201345. https:\/\/doi.org\/10.1007\/s10549-018-5057-7.","journal-title":"Breast Cancer Res Treat."},{"issue":"1S1","key":"16805_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/01.GOX.0001005892.62910.1b","volume":"12","author":"S Subramaniam","year":"2024","unstructured":"Subramaniam S, Smith R, Mark SL. Surveillance vs. prophylactic mastectomy and reconstruction in BRCA1\/2 patients: a cost analysis study. Plast Reconstr Surg Global Open. 2024;12(1S1):11. https:\/\/doi.org\/10.1097\/01.GOX.0001005892.62910.1b.","journal-title":"Plast Reconstr Surg Global Open"},{"issue":"1","key":"16805_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1308\/rcsann.2023.0042","volume":"106","author":"J Morgan","year":"2024","unstructured":"Morgan J, MacInnes E, Erskine S, et al. Psychosocial outcomes after varying risk management strategies in women at increased familial breast cancer risk: a mixed methods study of patient and partner outcomes. Ann R Coll Surg Engl. 2024;106(1):78\u201391. https:\/\/doi.org\/10.1308\/rcsann.2023.0042.","journal-title":"Ann R Coll Surg Engl."},{"key":"16805_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13053-020-00152-z","volume":"18","author":"CA Mansfield","year":"2020","unstructured":"Mansfield CA, Metcalfe KA, Snyder C, et al. Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation. Hered Cancer Clin Pract. 2020;18:20. https:\/\/doi.org\/10.1186\/s13053-020-00152-z.","journal-title":"Hered Cancer Clin Pract."},{"issue":"3","key":"16805_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000503370","volume":"15","author":"R Segerer","year":"2020","unstructured":"Segerer R, Peschel C, K\u00e4mmerer U, H\u00e4ussler S, W\u00f6ckel A, Segerer S. Factors impacting on decision-making towards prophylactic surgeries in BRCA mutation carriers and women with familial predisposition. Breast Care. 2020;15(3):253\u20139. https:\/\/doi.org\/10.1159\/000503370.","journal-title":"Breast Care."},{"issue":"2","key":"16805_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41416-020-0861-3","volume":"123","author":"KA Metcalfe","year":"2020","unstructured":"Metcalfe KA, Price MA, Mansfield C, et al. Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis. Br J Cancer. 2020;123(2):268\u201374. https:\/\/doi.org\/10.1038\/s41416-020-0861-3.","journal-title":"Br J Cancer."},{"key":"16805_CR40","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2019.927","author":"R Vidya","year":"2019","unstructured":"Vidya R, Berna G, Sbitany H, et al. Prepectoral implant-based breast reconstruction: a joint consensus guide from UK, European and USA breast and plastic reconstructive surgeons. Ecancermedicalscience. 2019. https:\/\/doi.org\/10.3332\/ecancer.2019.927.","journal-title":"Ecancermedicalscience."},{"issue":"7","key":"16805_CR41","doi-asserted-by":"publisher","first-page":"e2332","DOI":"10.1097\/gox.0000000000002332","volume":"7","author":"AW Peled","year":"2019","unstructured":"Peled AW, Peled ZM. Nerve preservation and allografting for sensory innervation following immediate implant breast reconstruction. Plast Reconstr Surg Glob Open. 2019;7(7):e2332. https:\/\/doi.org\/10.1097\/gox.0000000000002332.","journal-title":"Plast Reconstr Surg Glob Open."},{"key":"16805_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/abs-21-9","volume":"6","author":"AW Peled","year":"2021","unstructured":"Peled AW, Peled ZM. Sensory reinnervation after mastectomy with implant-based reconstruction. Ann Breast Surg. 2021;6:27.","journal-title":"Ann Breast Surg."},{"key":"16805_CR43","doi-asserted-by":"publisher","DOI":"10.1200\/po.21.00233","author":"KF Mittendorf","year":"2021","unstructured":"Mittendorf KF, Knerr S, Kauffman TL, et al. Systemic barriers to risk-reducing interventions for hereditary cancer syndromes: implications for health care inequities. JCO Precis Oncol. 2021. https:\/\/doi.org\/10.1200\/po.21.00233.","journal-title":"JCO Precis Oncol."},{"issue":"4","key":"16805_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ajog.2023.03.045","volume":"229","author":"X Wei","year":"2023","unstructured":"Wei X, Oxley S, Sideris M, et al. Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis. Am J Obstet Gynecol. 2023;229(4):388-409.e4. https:\/\/doi.org\/10.1016\/j.ajog.2023.03.045.","journal-title":"Am J Obstet Gynecol."},{"issue":"6","key":"16805_CR45","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s11136-015-1181-6","volume":"25","author":"SN Razdan","year":"2016","unstructured":"Razdan SN, Patel V, Jewell S, McCarthy CM. Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes. Qual Life Res. 2016;25(6):1409\u201321. https:\/\/doi.org\/10.1007\/s11136-015-1181-6.","journal-title":"Qual Life Res."},{"issue":"12","key":"16805_CR46","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/j.pec.2017.06.032","volume":"100","author":"L Braude","year":"2017","unstructured":"Braude L, Kirsten L, Gilchrist J, Juraskova I. A systematic review of women\u2019s satisfaction and regret following risk-reducing mastectomy. Patient Educ Counsel. 2017;100(12):2182\u20139. https:\/\/doi.org\/10.1016\/j.pec.2017.06.032.","journal-title":"Patient Educ Counsel."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16805-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:28:45Z","timestamp":1741195725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16805-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["16805"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16805-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article. The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}